A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

Summary

This study will examine whether a single dose of PF-05230901 is safe and well tolerated when given to healthy volunteers by injection under the skin. An additional objective is to measure the blood concentrations of PF-05230901. Each dose will be tested in a different group of subjects starting from the lowest dose.

Timeline

Start

2010-11

Primary completion

2011-09

Completion

2011-09

Outcome

Outcome not reported

Stopped: “The study was terminated on 21-Sept-2011 due to the emergent safety concern of sensory symptoms.”

Drugs

Indications